Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 226

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 16C
Chunk 226
---
ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES

Brightman Almagor Zohar & Co., a Firm in the
Deloitte Global Network, an independent registered public accounting firm, or Deloitte, has served as our principal independent registered
public accounting firm for the year ended October 31, 2024.

The following table provides
information regarding fees paid or to be paid by us to Brightman Almagor Zohar & Co., a firm in the Deloitte Global Network, an independent
registered public accounting firm, for all services, including audit services, for the years ended October 31, 2024, and 2023:

                          Year Ended                
                          October 31,               
  (USD)                   2024                      
 ────────────────────────────────────────────────────
  Audit fees (1)          150,000          180,000  
  Audit-related fees      -                -        
  Tax fees                6,244            -        
  All other fees          -                -        
  Total                   156,244          180,000  

  (1)      Audit fees consist of professional services provided              

Pre-Approval of Auditors’ Compensation

Our Audit Committee has a pre-approval policy
for the engagement of our independent registered public accounting firm to perform certain audit and non-audit services. Pursuant to
this policy, which is designed to assure that such engagements do not impair the independence of our auditors, the Audit Committee pre-approves
annually a catalog of specific audit and non-audit services in the categories of audit services, audit-related services and tax services
that may be performed by our independent registered public accounting firm. If a type of service, that is to be provided by our auditors,
has not received such general pre-approval, it will require specific pre-approval by our Audit Committee. The policy prohibits retention
of the independent registered public accounting firm to perform the prohibited non-audit functions defined in applicable SEC rules.

ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES